PER
Click for more information
2.35% 8.7¢ percheron therapeutics limited

If the Board say no CR needed until mid 2020, I expect a $$$...

  1. Uboy
    4,683 Posts.
    lightbulb Created with Sketch. 1086
    clock Created with Sketch.
    12/12/19
    06:13
    Post #: 41922973
    If the Board say no CR needed until mid 2020, I expect a $$$ partnership of sorts to be announced.

    $2m won’t be enough to get Euro Phase 2b going and make FDA progress.

    Will Sarepta play ball?

    Will Ionis come back to the fold?

    Licnsing out ATL1103?

    Dunno, but if they were all smiling like Cheshire cats at the AGM...something is up.

    .
    ANP Price at posting: 8.2¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 10  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Microcap Madness: 5 junior explorers with news out on Thursday 20 June
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
GYG Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢ 		Change
0.002(2.35%) 		Mkt cap ! $78.43M
Open High Low Value Volume
8.6¢ 8.9¢ 8.5¢ $53.40K 614.3K

Buyers (Bids)

No. Vol. Price($)
1 49999 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 67263 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.